Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,158 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07282756Recruiting
Lovastatin gel for gum disease treatment
This study tests whether a lovastatin gel applied to the gums (after a deep cleaning) helps treat gum disease better than cleaning alone. Participants must not have had previous gum treatment or antibiotics recently, and can be a smoker or non-smoker.
Bielsko-Biala, Silesian VoivodeshipAges 18–59 - NCT07282483RecruitingPhase 2
Chinese medicine mouthwash for radiation mouth sores
This trial tests whether a traditional Chinese medicine mouthwash and oral liquid can help prevent or reduce mouth sores caused by radiation therapy for head and neck cancer. If you are getting radiation and are at risk for these painful sores, this study might offer you extra relief.
Chengdu, SichuanAges 18–65 - NCT07286188RecruitingPhase 4
Misoprostol for fluid use in fibroid surgery
This study tests if giving misoprostol (a medication given as a rectal suppository) during a hysteroscopic myomectomy helps reduce the amount of fluid used during the surgery. It may lead to a safer procedure for removing small uterine fibroids.
Chicago, IllinoisAges 18–50 - NCT07282821RecruitingPhase 2
Bempedoic acid for polycystic kidney disease
This trial tests if the cholesterol-lowering drug bempedoic acid can slow kidney function loss in people with autosomal dominant polycystic kidney disease (ADPKD). It may offer a new option to protect your kidneys.
Baltimore, MarylandAges 18–60 - NCT07280520Enrolling by invitation
Luteolin supplement for athlete performance and metabolism
This study tests whether a daily luteolin supplement (a natural compound found in some plants) can improve how your muscles and fat cells use energy, boost your athletic performance, and change your body composition over 12 weeks.
Amman, Amman GovernorateAges 18–35 - NCT07286487Recruiting
Can licorice acid calm irritated skin?
This study tests whether a cream made from glycyrrhetinic acid (a natural compound found in licorice root) can soothe skin that has been intentionally irritated. If you are a healthy adult with normal skin, you can help see if this natural treatment works.
SplitAges 18 years+ - NCT07286747RecruitingPhase 2
Nicotinic Acid for Reversing Prediabetes
This trial tests whether a controlled-release form of nicotinic acid (a type of vitamin B3) can help people with prediabetes get their blood sugar back to normal. It also looks at how the treatment affects liver health.
BerlinAges 18–79 - NCT07279558RecruitingPhase 2
CBD and Alcohol Use Study
This study tests whether cannabidiol (CBD), a compound from cannabis, can help people who drink alcohol regularly reduce their drinking or change their drinking patterns. You may be eligible if you're 21-65, have used CBD or cannabis before, drink alcohol regularly, and don't take certain medications that could interfere.
Aurora, ColoradoAges 21–65 - NCT07282353RecruitingPhase 3
Study of CS0159 for primary biliary cholangitis with poor UDCA response
This trial tests an experimental drug (CS0159) for people with primary biliary cholangitis (PBC) who either didn't respond well to or couldn't take the standard treatment UDCA. It aims to improve liver function and reduce symptoms.
Hefei, AnhuiAges 18–75 - NCT07280702RecruitingPhase 4
Combination treatment for hard-to-control psoriatic disease
This trial tests adding a new oral medication (deucravacitinib) to your current anti-TNF therapy to see if it helps better control psoriatic arthritis or psoriasis that hasn't improved enough. It may be an option if you still have active symptoms despite being on a stable anti-TNF treatment for at least 6 months.
Dallas, TexasAges 18–65 - NCT07285031Recruiting
Histamines and blood vessel health study
This study looks at how histamines affect blood pressure and heart function in healthy young adults. You will visit the lab three times to help researchers understand these effects.
Kelowna, British ColumbiaAges 19–39 - NCT07280585RecruitingPhase 3
Testing a diabetes drug to slow kidney disease progression
This study tests whether a common diabetes medication (SGLT2 inhibitor) can help people with autosomal dominant polycystic kidney disease (ADPKD) maintain kidney function longer. If you have fast-growing kidney cysts and are between 18 and 60 years old, this trial may be an option.
FeldkirchAges 18–60 - NCT07281885Recruiting
Aromatherapy for nausea after joint replacement
This study tests whether aromatherapy with essential oils can help reduce nausea and vomiting after total joint replacement surgery. Participants will receive a simple aromatherapy treatment alongside their regular care.
Wong Tai Sin, Hong KongAges 18 years+ - NCT07287345RecruitingPhase 4
Colchicine’s effect on inflammation after heart bypass surgery
This trial tests whether the drug colchicine can reduce inflammation after planned coronary artery bypass graft (CABG) surgery. It may help patients recover better by lowering inflammatory markers.
Lexington, KentuckyAges 18–99 - NCT04924868RecruitingPhase 3
Ursodeoxycholic acid to prevent gallstone pancreatitis returning
This trial tests whether ursodeoxycholic acid (a bile medicine) can help prevent complications from gallstone-related acute pancreatitis from coming back after you leave the hospital. It may help reduce repeat problems linked to gallstones, especially after an initial pancreatitis episode.
Santiago de Compostela, A coruñaAges 18 years+ - NCT06459310RecruitingPhase 2
Testing metformin to slow aging in healthy men
This study tests whether metformin can help slow aging in healthy men. You might be eligible if you are a man in one of two age groups and do not have major health problems.
BeijingAges 18–65 - NCT06389110RecruitingPhase 3
Low-dose atropine drops to slow children's nearsightedness
This study tests whether a very low-dose atropine eye drop (0.01%) can safely slow down worsening nearsightedness in children. It is for kids ages 3 to 12 who are already nearsighted but haven't used other myopia control treatments before.
Mexico CityAges 3–12 - NCT07276581RecruitingPhase 2
Testing AZD1163 for active rheumatoid arthritis
This study tests a new medication called AZD1163 for people with rheumatoid arthritis (RA) that hasn't responded well enough to standard treatments. It aims to see if the drug can safely reduce joint swelling and pain.
Glendale, ArizonaAges 18 years+ - NCT07272434RecruitingPhase 3
RSV vaccine trial for adults 60 and older
This trial tests a new RSV vaccine for people aged 60 and above. RSV is a common virus that can cause serious breathing problems in older adults. The study will see if the vaccine is safe and helps protect you from RSV.
Guangzhou, GuangdongAges 60 years+ - NCT07276997RecruitingPhase 2
Study of Icalcaprant for major depressive disorder
This trial tests an oral medication called icalcaprant for adults with major depressive disorder (MDD). It aims to see if the drug can reduce depression symptoms and what side effects may occur.
Dothan, AlabamaAges 18–65 - NCT07271693RecruitingPhase 1
Safety study of a new medicine in healthy volunteers
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
ChristchurchAges 18–50 - NCT07275918RecruitingPhase 1
Study of SA1211 injection for chronic hepatitis B
This study tests a new injection called SA1211 for people with chronic hepatitis B. It will help see if the treatment is safe and how it works in the body.
Changchun, JilinAges 18–65 - NCT07275788RecruitingPhase 1
Study of REGEND003 for type 2 diabetes with kidney disease
This trial tests a new treatment, REGEND003, for people who have both type 2 diabetes and chronic kidney disease. The goal is to see if it can help manage these conditions together.
ShanghaiAges 30–75 - NCT07271186RecruitingPhase 2
Study of an experimental drug for kidney disease from type 2 diabetes
This study tests an investigational drug called ALN-ANG3 to see if it can help people with diabetic kidney disease. The drug may reduce kidney damage and slow down the loss of kidney function. If you join, you will get the study drug or a placebo (a dummy shot) and be followed by a study doctor.
Huntsville, AlabamaAges 18–80
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,158 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.